{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:43:36Z","timestamp":1790959416171,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1038\/ncpneuro0176","type":"journal-article","created":{"date-parts":[[2006,5,16]],"date-time":"2006-05-16T16:44:01Z","timestamp":1147797841000},"page":"264-275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":160,"title":["West Nile virus meningoencephalitis"],"prefix":"10.1038","volume":"2","author":[{"given":"Roberta L","family":"DeBiasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpneuro0176_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJM200106143442401","volume":"344","author":"D Nash","year":"2001","unstructured":"Nash D  et al. (2001) The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344: 1807\u20131814","journal-title":"N Engl J Med"},{"key":"BFncpneuro0176_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.virol.2005.07.022","volume":"342","author":"CT Davis","year":"2005","unstructured":"Davis CT  et al. (2005) Phylogenetic analysis of North American West Nile virus isolates, 2001\u20132004: evidence for the emergence of a dominant genotype. Virology 342: 252\u2013265","journal-title":"Virology"},{"key":"BFncpneuro0176_CR3","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3201\/eid1108.050289a","volume":"11","author":"EB Hayes","year":"2005","unstructured":"Hayes EB  et al. (2005) Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis 11: 1167\u20131173","journal-title":"Emerg Infect Dis"},{"key":"BFncpneuro0176_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1473-3099(04)01128-4","volume":"4","author":"BP Granwehr","year":"2004","unstructured":"Granwehr BP  et al. (2004) West Nile virus: where are we now? Lancet Infect Dis 4: 547\u2013556","journal-title":"Lancet Infect Dis"},{"key":"BFncpneuro0176_CR5","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/archneur.61.8.1190","volume":"61","author":"KL Tyler","year":"2004","unstructured":"Tyler KL (2004) West Nile virus infection in the United States. Arch Neurol 61: 1190\u20131195","journal-title":"Arch Neurol"},{"key":"BFncpneuro0176_CR6","unstructured":"Public Health Agency of Canada: West Nile Virus Surveillance Information [http:\/\/www.phac-aspc.gc.ca\/wnv-vwn]"},{"key":"BFncpneuro0176_CR7","unstructured":"Centers for Disease Control and Prevention [http:\/\/www.cdc.gov]"},{"key":"BFncpneuro0176_CR8","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","volume":"286","author":"RS Lanciotti","year":"1999","unstructured":"Lanciotti RS  et al. (1999) Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286: 2333\u20132337","journal-title":"Science"},{"key":"BFncpneuro0176_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1006\/viro.2002.1449","volume":"298","author":"RS Lanciotti","year":"2002","unstructured":"Lanciotti RS  et al. (2002) Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 298: 96\u2013105","journal-title":"Virology"},{"key":"BFncpneuro0176_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.virol.2004.09.016","volume":"330","author":"CT Davis","year":"2004","unstructured":"Davis CT  et al. (2004) Emergence of attenuated West Nile virus variants in Texas, 2003. Virology 330: 342\u2013350","journal-title":"Virology"},{"key":"BFncpneuro0176_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.4269\/ajtmh.2004.71.493","volume":"71","author":"GD Ebel","year":"2004","unstructured":"Ebel GD  et al. (2004) Genetic and phenotypic variation of West Nile virus in New York, 2000\u20132003. Am J Trop Med Hyg 71: 493\u2013500","journal-title":"Am J Trop Med Hyg"},{"key":"BFncpneuro0176_CR12","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3201\/eid0704.017426","volume":"7","author":"RS Nasci","year":"2001","unstructured":"Nasci RS  et al. (2001) West Nile virus in overwintering Culex mosquitoes, New York City, 2000. Emerg Infect Dis 7: 742\u2013744","journal-title":"Emerg Infect Dis"},{"key":"BFncpneuro0176_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0140-6736(01)05480-0","volume":"358","author":"F Mostashari","year":"2001","unstructured":"Mostashari F  et al. (2001) Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 358: 261\u2013264","journal-title":"Lancet"},{"key":"BFncpneuro0176_CR14","unstructured":"Centers for Disease Control and Prevention (2003) Update: Detection of West Nile virus in blood donations\u2014United States, 2003. MMWR Morb Mortal Wkly Rep 52: 916\u2013919"},{"key":"BFncpneuro0176_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1056\/NEJMe058144","volume":"353","author":"LR Petersen","year":"2005","unstructured":"Petersen LR and Epstein JS (2005) Problem solved? West Nile virus and transfusion safety. N Engl J Med 353: 516\u2013517","journal-title":"N Engl J Med"},{"key":"BFncpneuro0176_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.7326\/0003-4819-143-7-200510040-00007","volume":"143","author":"B Custer","year":"2005","unstructured":"Custer B  et al. (2005) The cost-effectiveness of screening the US blood supply for West Nile virus. Ann Intern Med 143: 486\u2013492","journal-title":"Ann Intern Med"},{"key":"BFncpneuro0176_CR17","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1056\/NEJMoa022987","volume":"348","author":"M Iwamoto","year":"2003","unstructured":"Iwamoto M  et al. (2003) Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 348: 2196\u20132203","journal-title":"N Engl J Med"},{"key":"BFncpneuro0176_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/01.TP.0000101434.98873.CB","volume":"77","author":"D DeSalvo","year":"2004","unstructured":"DeSalvo D  et al. (2004) West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. Transplantation 77: 466\u2013469","journal-title":"Transplantation"},{"key":"BFncpneuro0176_CR19","unstructured":"Centers for Disease Control and Prevention (2005) West Nile virus infections in organ transplant recipients\u2014New York and Pennsylvania, August\u2013September, 2005. MMWR Morb Mortal Wkly Rep 54: 1021\u20131023"},{"key":"BFncpneuro0176_CR20","unstructured":"Centers for Disease Control and Prevention (2002) Intrauterine West Nile virus infection\u2014New York, 2002. MMWR Morb Mortal Wkly Rep 51: 1135\u20131136"},{"key":"BFncpneuro0176_CR21","unstructured":"Centers for Disease Control and Prevention (2004) Interim guidelines for the evaluation of infants born to mothers infected with West Nile virus during pregnancy. MMWR Morb Mortal Wkly Rep 53: 154\u2013157"},{"key":"BFncpneuro0176_CR22","unstructured":"Centers for Disease Control and Prevention (2002) Laboratory-acquired West Nile virus infections\u2014United States, 2002. MMWR Morb Mortal Wkly Rep 51: 1133\u20131135"},{"key":"BFncpneuro0176_CR23","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","volume":"77","author":"MS Diamond","year":"2003","unstructured":"Diamond MS  et al. (2003) B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77: 2578\u20132586","journal-title":"J Virol"},{"key":"BFncpneuro0176_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7326\/0003-4819-141-5-200409070-00010","volume":"141","author":"JT Watson","year":"2004","unstructured":"Watson JT  et al. (2004) Clinical characteristics and functional outcomes of West Nile virus fever. Ann Intern Med 141: 360\u2013365","journal-title":"Ann Intern Med"},{"key":"BFncpneuro0176_CR25","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/nm1140","volume":"10","author":"T Wang","year":"2004","unstructured":"Wang T  et al. (2004) Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10: 1366\u20131373","journal-title":"Nat Med"},{"key":"BFncpneuro0176_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jama.290.4.511","volume":"290","author":"JJ Sejvar","year":"2003","unstructured":"Sejvar JJ  et al. (2003) Neurologic manifestations and outcome of West Nile virus infection. JAMA 290: 511\u2013515","journal-title":"JAMA"},{"key":"BFncpneuro0176_CR27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3201\/eid1107.040991","volume":"11","author":"JJ Sejvar","year":"2005","unstructured":"Sejvar JJ  et al. (2005) West Nile virus-associated flaccid paralysis. Emerg Infect Dis 11: 1021\u20131027","journal-title":"Emerg Infect Dis"},{"key":"BFncpneuro0176_CR28","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.3201\/eid1108.050289b","volume":"11","author":"EB Hayes","year":"2005","unstructured":"Hayes EB  et al. (2005) Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 11: 1174\u20131179","journal-title":"Emerg Infect Dis"},{"key":"BFncpneuro0176_CR29","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1056\/NEJMo020128","volume":"347","author":"LR Petersen","year":"2002","unstructured":"Petersen LR  et al. (2002) West Nile virus encephalitis. N Engl J Med 347: 1225\u20131226","journal-title":"N Engl J Med"},{"key":"BFncpneuro0176_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jns.2004.01.013","volume":"220","author":"R Brilla","year":"2004","unstructured":"Brilla R  et al. (2004) Clinical and neuroradiologic features of 39 consecutive cases of West Nile Virus meningoencephalitis. J Neurol Sci 220: 37\u201340","journal-title":"J Neurol Sci"},{"key":"BFncpneuro0176_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/153036604773083004","volume":"4","author":"DR O'Leary","year":"2004","unstructured":"O'Leary DR  et al. (2004) The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 4: 61\u201370","journal-title":"Vector Borne Zoonotic Dis"},{"key":"BFncpneuro0176_CR32","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/j.1600-6143.2004.00592.x","volume":"4","author":"D Kumar","year":"2004","unstructured":"Kumar D  et al. (2004) A seroprevalence study of West Nile virus infection in solid organ transplant recipients. Am J Transplant 4: 1883\u20131888","journal-title":"Am J Transplant"},{"key":"BFncpneuro0176_CR33","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/archneur.61.8.1210","volume":"61","author":"BK Kleinschmidt-DeMasters","year":"2004","unstructured":"Kleinschmidt-DeMasters BK  et al. (2004) Naturally-acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic and neuropathological features. Arch Neurol 61: 1210\u20131220","journal-title":"Arch Neurol"},{"key":"BFncpneuro0176_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pediatrneurol.2005.03.007","volume":"33","author":"RL DeBiasi","year":"2005","unstructured":"DeBiasi RL  et al. (2005) West Nile virus meningoencephalitis in an immunocompetent adolescent. Pediatr Neurol 33: 217\u2013219","journal-title":"Pediatr Neurol"},{"key":"BFncpneuro0176_CR35","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1542\/peds.2004-0491","volume":"114","author":"R Yim","year":"2004","unstructured":"Yim R  et al. (2004) Spectrum of clinical manifestations of West Nile virus infection in children. Pediatrics 114: 1673\u20131675","journal-title":"Pediatrics"},{"key":"BFncpneuro0176_CR36","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1542\/peds.113.5.1375","volume":"113","author":"EB Hayes","year":"2004","unstructured":"Hayes EB and O'Leary DR (2004) West Nile virus infection: a pediatric perspective. Pediatrics 113: 1375\u20131381","journal-title":"Pediatrics"},{"key":"BFncpneuro0176_CR37","doi-asserted-by":"publisher","first-page":"11311","DOI":"10.1073\/pnas.172195399","volume":"99","author":"T Mashimo","year":"2002","unstructured":"Mashimo T  et al. (2002) A nonsense mutation in the gene encoding 2\u2032-5\u2032-oligoadenylate synthetase\/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci USA 99: 11311\u201311316","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneuro0176_CR38","doi-asserted-by":"publisher","first-page":"9322","DOI":"10.1073\/pnas.142287799","volume":"99","author":"AA Perelygin","year":"2002","unstructured":"Perelygin AA  et al. (2002) Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci USA 99: 9322\u20139327","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneuro0176_CR39","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1074\/jbc.M508649200","volume":"281","author":"A Kajaste-Rudnitski","year":"2006","unstructured":"Kajaste-Rudnitski A  et al. (2006) The 2\u20325\u2032 oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells. J Biol Chem 281: 4624\u20134637","journal-title":"J Biol Chem"},{"key":"BFncpneuro0176_CR40","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1086\/497340","volume":"192","author":"I Yakub","year":"2005","unstructured":"Yakub I  et al. (2005) Single nucleotide polymorphisms in genes for 2\u20325\u2032-oligoadenylate synthetase and RNase L in patients hospitalized with West Nile virus infection. J Infect Dis 192: 1741\u20131748","journal-title":"J Infect Dis"},{"key":"BFncpneuro0176_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/088282403322396082","volume":"16","author":"MS Diamond","year":"2003","unstructured":"Diamond MS  et al. (2003) Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol 16: 259\u2013278","journal-title":"Viral Immunol"},{"key":"BFncpneuro0176_CR42","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","volume":"78","author":"B Shrestha","year":"2004","unstructured":"Shrestha B and Diamond MS (2004) Role of CD8+ T cells in control of West Nile virus infection. J Virol 78: 8312\u20138321","journal-title":"J Virol"},{"key":"BFncpneuro0176_CR43","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1128\/JVI.79.12.7466-7477.2005","volume":"79","author":"E Mehlhop","year":"2005","unstructured":"Mehlhop E  et al. (2005) Complement activation is required for induction of a protective antibody response against West Nile virus infection. J Virol 79: 7466\u20137477","journal-title":"J Virol"},{"key":"BFncpneuro0176_CR44","doi-asserted-by":"publisher","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","volume":"79","author":"MA Samuel","year":"2005","unstructured":"Samuel MA and Diamond MS (2005) Alpha\/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79: 13350\u201313361","journal-title":"J Virol"},{"key":"BFncpneuro0176_CR45","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1084\/jem.20042530","volume":"202","author":"WG Glass","year":"2005","unstructured":"Glass WG  et al. (2005) Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 202: 1087\u20131098","journal-title":"J Exp Med"},{"key":"BFncpneuro0176_CR46","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.1128\/JVI.79.17.11457-11466.2005","volume":"79","author":"RS Klein","year":"2005","unstructured":"Klein RS  et al. (2005) Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 79: 11457\u201311466","journal-title":"J Virol"},{"key":"BFncpneuro0176_CR47","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3201\/eid0903.020531","volume":"9","author":"JT Roehrig","year":"2003","unstructured":"Roehrig JT  et al. (2003) Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 9: 376\u2013379","journal-title":"Emerg Infect Dis"},{"key":"BFncpneuro0176_CR48","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1128\/JCM.43.12.5873-5875.2005","volume":"43","author":"PN Levett","year":"2005","unstructured":"Levett PN  et al. (2005) Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus. J Clin Microbiol 43: 5873\u20135875","journal-title":"J Clin Microbiol"},{"key":"BFncpneuro0176_CR49","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1128\/JCM.39.12.4506-4513.2001","volume":"39","author":"RS Lanciotti","year":"2001","unstructured":"Lanciotti RS and Kerst AJ (2001) Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses. J Clin Microbiol 39: 4506\u20134513","journal-title":"J Clin Microbiol"},{"key":"BFncpneuro0176_CR50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1212\/01.wnl.0000195890.70898.1f","volume":"14","author":"KL Tyler","year":"2006","unstructured":"Tyler KL  et al. (2006) CSF findings in 250 patients with serologically confirmed West Nile Virus meningitis and encephalitis. Neurology 14: 361\u2013365","journal-title":"Neurology"},{"key":"BFncpneuro0176_CR51","first-page":"289","volume":"26","author":"M Ali","year":"2005","unstructured":"Ali M  et al. (2005) West Nile virus infection: MR imaging findings in the nervous system. AJNR Am J Neuroradiol 26: 289\u2013297","journal-title":"AJNR Am J Neuroradiol"},{"key":"BFncpneuro0176_CR52","first-page":"1986","volume":"26","author":"KA Petropoulou","year":"2005","unstructured":"Petropoulou KA  et al. (2005) West Nile virus meningoencephalitis: MR imaging findings. AJNR Am J Neuroradiol 26: 1986\u20131995","journal-title":"AJNR Am J Neuroradiol"},{"key":"BFncpneuro0176_CR53","first-page":"1741","volume":"24","author":"HJ Robertson","year":"2003","unstructured":"Robertson HJ and Sejvar JJ (2003) The need for a West Nile virus MRI registry. AJNR Am J Neuroradiol 24: 1741\u20131742","journal-title":"AJNR Am J Neuroradiol"},{"key":"BFncpneuro0176_CR54","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3201\/eid1008.030879","volume":"10","author":"AL Klee","year":"2004","unstructured":"Klee AL  et al. (2004) Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 10: 1405\u20131411","journal-title":"Emerg Infect Dis"},{"key":"BFncpneuro0176_CR55","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.apmr.2004.04.038","volume":"85","author":"C Marciniak","year":"2004","unstructured":"Marciniak C  et al. (2004) Acute flaccid paralysis associated with West Nile virus: motor and functional improvement in 4 patients. Arch Phys Med Rehabil 85: 1933\u20131938","journal-title":"Arch Phys Med Rehabil"},{"key":"BFncpneuro0176_CR56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jns.2005.05.007","volume":"236","author":"NJ Cao","year":"2005","unstructured":"Cao NJ  et al. (2005) Recovery and prognosticators of paralysis in West Nile virus infection. J Neurol Sci 236: 73\u201380","journal-title":"J Neurol Sci"},{"key":"BFncpneuro0176_CR57","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.apmr.2004.10.019","volume":"86","author":"N Rao","year":"2005","unstructured":"Rao N  et al. (2005) Rehabilitation outcomes of 5 patients with severe West Nile virus infection: a case series. Arch Phys Med Rehabil 86: 449\u2013452","journal-title":"Arch Phys Med Rehabil"},{"key":"BFncpneuro0176_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/095632020401500202","volume":"15","author":"JD Morrey","year":"2004","unstructured":"Morrey JD  et al. (2004) Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antivir Chem Chemother 15: 101\u2013109","journal-title":"Antivir Chem Chemother"},{"key":"BFncpneuro0176_CR59","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3201\/eid0704.017414","volume":"7","author":"MY Chowers","year":"2001","unstructured":"Chowers MY  et al. (2001) Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 7: 675\u2013678","journal-title":"Emerg Infect Dis"},{"key":"BFncpneuro0176_CR60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/095632020401500104","volume":"15","author":"M Bretner","year":"2004","unstructured":"Bretner M  et al. (2004) Synthesis and evaluation of ATP-binding site directed potential inhibitors of nucleoside triphosphatases\/helicases and polymerases of hepatitis C and other selected Flaviviridae viruses. Antivir Chem Chemother 15: 35\u201342","journal-title":"Antivir Chem Chemother"},{"key":"BFncpneuro0176_CR61","unstructured":"Rahal JJ and Wehbeh WA (2004) Double-blind placebo controlled trial of alpha-interferon for West Nile virus meningoencephalitis. Protocol WIN-102, revised 7\/26\/2004 [http:\/\/www.nyhq.org\/posting\/rahal.html] (accessed 9 March 2006)"},{"key":"BFncpneuro0176_CR62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1086\/376870","volume":"188","author":"D Ben Nathan","year":"2003","unstructured":"Ben Nathan D  et al. (2003) Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis 188: 5\u201312","journal-title":"J Infect Dis"},{"key":"BFncpneuro0176_CR63","doi-asserted-by":"publisher","first-page":"12941","DOI":"10.1128\/JVI.77.24.12941-12949.2003","volume":"77","author":"MJ Engle","year":"2003","unstructured":"Engle MJ and Diamond MS (2003) Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice. J Virol 77: 12941\u201312949","journal-title":"J Virol"},{"key":"BFncpneuro0176_CR64","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3201\/eid0704.017432","volume":"7","author":"Z Shimoni","year":"2001","unstructured":"Shimoni Z  et al. (2001) Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg Infect Dis 7: 759","journal-title":"Emerg Infect Dis"},{"key":"BFncpneuro0176_CR65","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1034\/j.1399-3062.2002.01014.x","volume":"4","author":"A Hamdan","year":"2002","unstructured":"Hamdan A  et al. (2002) Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transpl Infect Dis 4: 160\u2013162","journal-title":"Transpl Infect Dis"},{"key":"BFncpneuro0176_CR66","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1086\/377172","volume":"37","author":"M Haley","year":"2003","unstructured":"Haley M  et al. (2003) The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis. Clin Infect Dis 37: e88\u2013e90","journal-title":"Clin Infect Dis"},{"key":"BFncpneuro0176_CR67","doi-asserted-by":"publisher","first-page":"545","DOI":"10.7326\/0003-4819-140-7-200404060-00015","volume":"140","author":"J Gea-Banacloche","year":"2004","unstructured":"Gea-Banacloche J  et al. (2004) West Nile virus: pathogenesis and therapeutic options. Ann Intern Med 140: 545\u2013553","journal-title":"Ann Intern Med"},{"key":"BFncpneuro0176_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/376871","volume":"188","author":"AG Agrawal","year":"2003","unstructured":"Agrawal AG and Petersen LR (2003) Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis 188: 1\u20134","journal-title":"J Infect Dis"},{"key":"BFncpneuro0176_CR69","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nm1240","volume":"11","author":"T Oliphant","year":"2005","unstructured":"Oliphant T  et al. (2005) Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 11: 522\u2013530","journal-title":"Nat Med"},{"key":"BFncpneuro0176_CR70","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nature03956","volume":"437","author":"GE Nybakken","year":"2005","unstructured":"Nybakken GE  et al. (2005) Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437: 764\u2013769","journal-title":"Nature"},{"key":"BFncpneuro0176_CR71","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1128\/JVI.79.8.4599-4609.2005","volume":"79","author":"TS Deas","year":"2005","unstructured":"Deas TS  et al. (2005) Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J Virol 79: 4599\u20134609","journal-title":"J Virol"},{"key":"BFncpneuro0176_CR72","unstructured":"An exploratory study of AVI-4020 in patients with possible acute neuroinvasive West Nile virus (WNV) disease [http:\/\/www.clinicaltrials.gov\/ct\/show\/NCT00091845]"},{"key":"BFncpneuro0176_CR73","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1743-422X-2-53","volume":"2","author":"BJ Geiss","year":"2005","unstructured":"Geiss BJ  et al. (2005) Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA. Virol J 2: 53","journal-title":"Virol J"},{"key":"BFncpneuro0176_CR74","first-page":"221","volume":"18","author":"JM Minke","year":"2004","unstructured":"Minke JM  et al. (2004) Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch Virol Suppl 18: 221\u2013230","journal-title":"Arch Virol Suppl"},{"key":"BFncpneuro0176_CR75","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2460\/ajvr.2004.65.1459","volume":"65","author":"L Siger","year":"2004","unstructured":"Siger L  et al. (2004) Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses. Am J Vet Res 65: 1459\u20131462","journal-title":"Am J Vet Res"},{"key":"BFncpneuro0176_CR76","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4269\/ajtmh.2002.66.115","volume":"66","author":"N Kanesa-Thasan","year":"2002","unstructured":"Kanesa-Thasan N  et al. (2002) Short report: absence of protective neutralizing antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am J Trop Med Hyg 66: 115\u2013116","journal-title":"Am J Trop Med Hyg"},{"key":"BFncpneuro0176_CR77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/vbz.2005.5.137","volume":"5","author":"BW Johnson","year":"2005","unstructured":"Johnson BW  et al. (2005) West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector Borne Zoonotic Dis 5: 137\u2013145","journal-title":"Vector Borne Zoonotic Dis"},{"key":"BFncpneuro0176_CR78","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0042-6822(03)00450-1","volume":"314","author":"AG Pletnev","year":"2003","unstructured":"Pletnev AG  et al. (2003) Molecularly engineered live-attenuated chimeric West Nile\/dengue virus vaccines protect rhesus monkeys from West Nile virus. Virology 314: 190\u2013195","journal-title":"Virology"},{"key":"BFncpneuro0176_CR79","doi-asserted-by":"publisher","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","volume":"78","author":"J Arroyo","year":"2004","unstructured":"Arroyo J  et al. (2004) ChimeriVax\u2013West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J Virol 78: 12497\u201312507","journal-title":"J Virol"},{"key":"BFncpneuro0176_CR80","unstructured":"Acambis (online 20 December 2005) Acambis becomes first company to enter Phase II testing of vaccine against West Nile virus. [http:\/\/www.acambis.com\/default.asp?id=1446] (accessed 9 March 2006)"},{"key":"BFncpneuro0176_CR81","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.med.57.121304.131418","volume":"57","author":"EB Hayes","year":"2006","unstructured":"Hayes EB and Gubler DJ (2006) Epidemiology and clinical features of an emerging epidemic in the United States. Ann Rev Med 57: 181\u2013194","journal-title":"Ann Rev Med"}],"container-title":["Nature Clinical Practice Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0176","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpneuro0176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:22:51Z","timestamp":1744370571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["BFncpneuro0176"],"URL":"https:\/\/doi.org\/10.1038\/ncpneuro0176","relation":{},"ISSN":["1745-834X","1745-8358"],"issn-type":[{"value":"1745-834X","type":"print"},{"value":"1745-8358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"10 January 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KL Tyler has received consulting fees from MacroGenics (Rockville, MD), a company involved in the development of a humanized monoclonal antibody for the treatment of West Nile virus infection. RL DeBiasi declared she has no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}